Challenging cases encountered in colorectal cancer screening for Lynch syndrome reveal novel findings: Nucleolar MSH6 staining and impact of prior chemoradiation therapy

Oana M. Radu, Marina N. Nikiforova, Linda Farkas, Alyssa M. Krasinskas

Research output: Contribution to journalArticle

37 Citations (Scopus)

Abstract

Many pathology laboratories have developed specific screening protocols to detect patients with Lynch syndrome. With recent recommendations to test all patients with newly diagnosed colorectal cancer for Lynch syndrome, the volume of testing will increase, and the most economic and reliable screening test will prevail. Although the detection of microsatellite instability by polymerase chain reaction and the detection of loss of the mismatch repair proteins by immunohistochemistry can each be used as a screening tool, each methodology has its strengths and weaknesses. During the time of our study, we used both polymerase chain reaction and immunohistochemistry to screen for Lynch syndrome in colorectal cancer specimens. We encountered 21 cases that posed significant interpretive challenges. A previously unpublished pattern of nucleolar MSH6 staining and potential spurious results induced by chemoradiation therapy are described. We feel that it is important to report these cases so that potential pitfalls in screening for Lynch syndrome can be avoided.

Original languageEnglish (US)
Pages (from-to)1247-1258
Number of pages12
JournalHuman Pathology
Volume42
Issue number9
DOIs
StatePublished - Sep 1 2011
Externally publishedYes

Fingerprint

Hereditary Nonpolyposis Colorectal Neoplasms
Early Detection of Cancer
Colorectal Neoplasms
Staining and Labeling
Immunohistochemistry
Polymerase Chain Reaction
Microsatellite Instability
DNA Mismatch Repair
Therapeutics
Economics
Pathology
Proteins

Keywords

  • Chemoradiation therapy
  • Lynch syndrome
  • Microsatellite instability
  • Mismatch repair proteins
  • MSH6

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Challenging cases encountered in colorectal cancer screening for Lynch syndrome reveal novel findings : Nucleolar MSH6 staining and impact of prior chemoradiation therapy. / Radu, Oana M.; Nikiforova, Marina N.; Farkas, Linda; Krasinskas, Alyssa M.

In: Human Pathology, Vol. 42, No. 9, 01.09.2011, p. 1247-1258.

Research output: Contribution to journalArticle

@article{bd432c9de31a4d1b9315664ebcfababe,
title = "Challenging cases encountered in colorectal cancer screening for Lynch syndrome reveal novel findings: Nucleolar MSH6 staining and impact of prior chemoradiation therapy",
abstract = "Many pathology laboratories have developed specific screening protocols to detect patients with Lynch syndrome. With recent recommendations to test all patients with newly diagnosed colorectal cancer for Lynch syndrome, the volume of testing will increase, and the most economic and reliable screening test will prevail. Although the detection of microsatellite instability by polymerase chain reaction and the detection of loss of the mismatch repair proteins by immunohistochemistry can each be used as a screening tool, each methodology has its strengths and weaknesses. During the time of our study, we used both polymerase chain reaction and immunohistochemistry to screen for Lynch syndrome in colorectal cancer specimens. We encountered 21 cases that posed significant interpretive challenges. A previously unpublished pattern of nucleolar MSH6 staining and potential spurious results induced by chemoradiation therapy are described. We feel that it is important to report these cases so that potential pitfalls in screening for Lynch syndrome can be avoided.",
keywords = "Chemoradiation therapy, Lynch syndrome, Microsatellite instability, Mismatch repair proteins, MSH6",
author = "Radu, {Oana M.} and Nikiforova, {Marina N.} and Linda Farkas and Krasinskas, {Alyssa M.}",
year = "2011",
month = "9",
day = "1",
doi = "10.1016/j.humpath.2010.11.016",
language = "English (US)",
volume = "42",
pages = "1247--1258",
journal = "Human Pathology",
issn = "0046-8177",
publisher = "W.B. Saunders Ltd",
number = "9",

}

TY - JOUR

T1 - Challenging cases encountered in colorectal cancer screening for Lynch syndrome reveal novel findings

T2 - Nucleolar MSH6 staining and impact of prior chemoradiation therapy

AU - Radu, Oana M.

AU - Nikiforova, Marina N.

AU - Farkas, Linda

AU - Krasinskas, Alyssa M.

PY - 2011/9/1

Y1 - 2011/9/1

N2 - Many pathology laboratories have developed specific screening protocols to detect patients with Lynch syndrome. With recent recommendations to test all patients with newly diagnosed colorectal cancer for Lynch syndrome, the volume of testing will increase, and the most economic and reliable screening test will prevail. Although the detection of microsatellite instability by polymerase chain reaction and the detection of loss of the mismatch repair proteins by immunohistochemistry can each be used as a screening tool, each methodology has its strengths and weaknesses. During the time of our study, we used both polymerase chain reaction and immunohistochemistry to screen for Lynch syndrome in colorectal cancer specimens. We encountered 21 cases that posed significant interpretive challenges. A previously unpublished pattern of nucleolar MSH6 staining and potential spurious results induced by chemoradiation therapy are described. We feel that it is important to report these cases so that potential pitfalls in screening for Lynch syndrome can be avoided.

AB - Many pathology laboratories have developed specific screening protocols to detect patients with Lynch syndrome. With recent recommendations to test all patients with newly diagnosed colorectal cancer for Lynch syndrome, the volume of testing will increase, and the most economic and reliable screening test will prevail. Although the detection of microsatellite instability by polymerase chain reaction and the detection of loss of the mismatch repair proteins by immunohistochemistry can each be used as a screening tool, each methodology has its strengths and weaknesses. During the time of our study, we used both polymerase chain reaction and immunohistochemistry to screen for Lynch syndrome in colorectal cancer specimens. We encountered 21 cases that posed significant interpretive challenges. A previously unpublished pattern of nucleolar MSH6 staining and potential spurious results induced by chemoradiation therapy are described. We feel that it is important to report these cases so that potential pitfalls in screening for Lynch syndrome can be avoided.

KW - Chemoradiation therapy

KW - Lynch syndrome

KW - Microsatellite instability

KW - Mismatch repair proteins

KW - MSH6

UR - http://www.scopus.com/inward/record.url?scp=80051679968&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80051679968&partnerID=8YFLogxK

U2 - 10.1016/j.humpath.2010.11.016

DO - 10.1016/j.humpath.2010.11.016

M3 - Article

C2 - 21334712

AN - SCOPUS:80051679968

VL - 42

SP - 1247

EP - 1258

JO - Human Pathology

JF - Human Pathology

SN - 0046-8177

IS - 9

ER -